Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
13.00
-0.40 (-2.99%)
Jan 23, 2025, 12:28 PM EST - Market open
Arcus Biosciences Revenue
Arcus Biosciences had revenue of $48.00M in the quarter ending September 30, 2024, with 50.00% growth. This brings the company's revenue in the last twelve months to $263.00M, up 119.17% year-over-year. In the year 2023, Arcus Biosciences had annual revenue of $117.00M with 4.46% growth.
Revenue (ttm)
$263.00M
Revenue Growth
+119.17%
P/S Ratio
4.38
Revenue / Employee
$455,806
Employees
577
Market Cap
1.19B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
RCUS News
- 1 day ago - Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer - Business Wire
- 8 days ago - Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 - Seeking Alpha
- 10 days ago - Arcus: Excellent Pipeline And Collaborations, Cash Runway - Seeking Alpha
- 4 weeks ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 4 weeks ago - Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 2 months ago - Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update - Business Wire